Michaël joined Accellix’s board in June 2020 as part of the bioMérieux investment in Accellix. Michaël is Vice President of the Healthcare Business within the Industrial Microbiology Unit of bioMérieux. Michaël leads a team dedicated to developing and providing best in class Quality Control solutions for the Pharma Industry.
Michaël joined bioMérieux in 2011 as Special Adviser to the President and CEO and secretary of the Executive Committee. He then joined the Industrial Microbiology Unit, where he was in charge of Strategy, Innovation and Portfolio Management. Michaël was appointed as VP of the Healthcare Business in 2015. Prior to joining bioMérieux, Michael held various responsibilities within the French public administration, in the field of economic development and competitiveness.